The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

COVID-19 Solutions at Cornell University

Latest Innovations Immediately Available

The following are select COVID-19 related technologies ready for commercialization

 

 

Therapeutics


Dromedary Camel Neutralizing Antibodies Against SARS-CoV-2This technology describes neutralizing antibodies sourced from dromedary camels that are effective against SARS-CoV-2 and related coronaviruses. Read more

 

 

 

Personal Protective Equipment (PPE)


Vacuum Helmet to Contain Wearer-Expelled Aerosols During Medical ProceduresThis technology is a vacuum helmet that prevents the spread of patient aerosols during medical examinations and procedures while maintaining easy access to the patient’s nose and mouth. Read more

 

 

 

More Cornell COVID-19 Technologies

 

Connect With a Member of the Licensing and Business Development Team

 

 

Connecting and Collaborating with Cornell

Didn’t find the technology you’re looking for? Cornell University’s faculty, researchers, and entrepreneurs are accelerating and developing viable solutions to challenges created by the COVID-19 pandemic.

 

On our Ithaca and Cornell Tech campuses, CTL’s Innovation Partnerships and Business Development teams actively track innovations and exciting research across the entire enterprise.

 

Connect with a member of the Cornell team to learn more about our latest faculty research and collaboration opportunities.

 

Cornell Pledges to Licensing Frameworks for Rapid Utilization of COVID-19 Technologies

 

Cornell has joined with other leading research institutions in committing to making promising technologies available and has pledged to special licensing frameworks to help foster a rapid response to COVID-19 including the COVID-19 Technology Access Framework and AUTM’s COVID-19 Licensing Guidelines. Read more

 

 

Cornell Programs to Promote Commercialization and Partnership